Latest Capital Raises News

Arena REIT reports a striking 87% increase in net profit for the half-year ended December 2024, driven by property revaluations and rental growth. Distributions per security also rose, reflecting confidence in the group’s long-term strategy.

Sarama Resources has completed the second tranche of its A$2 million equity placement, issuing options to institutional investors after shareholder approval. The funds are earmarked for advancing exploration and supporting working capital.

Bryah Resources has successfully completed the first tranche of its capital raising, securing $370,542 to fund copper exploration and working capital. The company now looks ahead to shareholder approval for the next phase of its placement.

Elixir Energy Limited has had its ASX trading suspension lifted following a pivotal announcement about expanding its Taroom Trough assets and initiating a capital raise.

Elixir Energy has expanded its footprint in Queensland's Taroom Trough through a farmin deal with Santos, boosting its contingent gas resources by 68% and launching a $9 million equity raise to fund upcoming exploration activities.

Amaero has completed a A$22 million institutional placement, concluding nearly A$100 million raised since 2022 and positioning itself for commercialisation in FY2026 with a robust balance sheet.

Resouro Strategic Metals Inc. posted a $5.28 million net loss for the nine months ended December 31, 2024, reflecting increased exploration and administrative expenses as it advances its Tiros Titanium and Rare Earth Elements Project. The company bolstered its balance sheet with a successful ASX dual listing and private placements but faces ongoing challenges to sustain operations.

Mantle Minerals Limited has announced a significant 10-for-1 consolidation of its ordinary shares and performance rights, set to reshape its capital structure by March 2025. This move aims to streamline the company’s share register ahead of renewed market activity.

Lodestar Minerals has increased its capital raising placement by $22,500, bringing the total to $542,500, subject to shareholder approval at an upcoming meeting.

Sarytogan Graphite Limited has received A$2.36 million from the EBRD as part of a second tranche equity investment, boosting the bank’s stake to 17.3%. An independent peer review affirms the project’s promise while highlighting manageable risks.

Alterity Therapeutics has raised A$40 million through a two-tranche placement to advance its lead compound ATH434 for neurodegenerative diseases, including Multiple System Atrophy and Parkinson's disease.

Inventis Limited updates its operational review with corrected financials, securing major orders and pursuing significant capital raises to fuel international expansion.